A team of researchers from the University at Albany, State University of New York has developed DNA nanoswitches that can detect the presence of ribonucleases (RNases) which are enzymes that degrade RNA. RNases can pose problems for biomedical research involving RNA, so detecting RNases can help to identify contamination in biological samples. RNases also have biological relevance, such as in the proliferation of retroviruses such as HIV, where RNase inhibitors have been considered for drug development.
The study, led by Arun Richard Chandrasekaran and Ken Halvorsen of The RNA Institute at State University of New York at Albany was published this week in Cell Reports Physical Sciences. The work also includes contribution by undergraduate researcher Ruju Trivedi.
Current techniques for RNase detection typically involve fluorescence analyses and multiple processing steps. The team used structure-changing DNA nanoswitches that turn from “signal-on” to “signal-off” in the presence of RNases, giving a direct readout using the common lab method of gel electrophoresis. In the study, the researchers were able to detect low levels of RNase H and used the detection to screen enzyme inhibitors that are considered as drug candidates for HIV.
In addition to RNase detection, the scientists used the nanoswitches to act as a molecular information processing system. Expanding previous work on DNA-based rewritable memory, the researchers encoded 5-bit information into DNA nanoswitches and used RNases as molecular erasers to delete all or part of this written information.
The team believes that the new development adds value to the existing suite of applications of the DNA nanoswitches that includes detection of nucleic acid biomarkers such as microRNAs, viral RNAs (including SARS-CoV-2) and as a platform for analyzing molecular interactions.
Read the full article (open access) here.